18 articles
Alongside the draft pharmaceutical guidelines, the CGPDTM has released Draft Guidelines for Examination of Patent Applications in the Field of Biotechnology, 2026 for public comment. The draft substantially…
The Delhi High Court has issued an interim injunction restraining Zydus from launching its Nivolumab biosimilar, siding with Squibb’s claim of imminent patent infringement.
In a recent decision, the Calcutta High Court upheld an appeal filed by BTS Research International Pty Ltd (“BTS”) challenging the rejection by the Assistant Controller of Patents…
The Madras High Court ruled that methods for producing antibodies in genetically modified animals are patentable under Indian law and are not excluded by Section 3(i). This decision…
The Madras High Court held that Section 3c of the Patents Act, 1970 does not exclude engineered non-living substances from patent protection. The ruling clarifies the distinction between…
This post analyses the Mayo v Prometheus case and its impact on the patentability of laws of nature in the US. It explains the judicial reasoning that established…
The Canadian Supreme Court's decision in the Harvard oncomouse case established that higher life forms are not patentable subject matter under Canadian law. While process claims were accepted,…
The post provides a detailed analysis of the criteria for patentability of biotechnology inventions in India, focusing on statutory exclusions and legal requirements. It further outlines how industrial…
This post provides an analytical review of non-obviousness standards for biotechnology inventions in the USA, referencing key Federal Circuit decisions. It discusses the evolving judicial approach and inconsistencies…
This post provides an analytical overview of the patentability of biotech inventions in the USA, focusing on statutory exclusions and major judicial decisions. It explains how US courts…